China Pharma Holdings
Open
$0.75
Prev. Close
$0.75
High
$0.80
Low
$0.75
Market Snapshot
$3.93M
-1.1
-2.66
$4.53M
224
China Pharma Holdings, Inc. engages in the development, manufacture, and marketing of pharmaceutical products. The company is headquartered in Haikou, Hainan and currently employs 215 full-time employees. The company went IPO on 2000-02-15. The firm is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for high-incidence and high-mortality diseases and medical conditions prevalent in the PRC. The firm's products include dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The firm's products and solutions are mainly applied in the treatment of various diseases and medical conditions. The firm mainly operates in the domestic market.
China Pharma Holdings, Inc. engages in the development, manufacture, and marketing of pharmaceutical products. The company is headquartered in Haikou, Hainan and currently employs 215 full-time employees. The company went IPO on 2000-02-15. The firm is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for high-incidence and high-mortality diseases and medical conditions prevalent in the PRC. The firm's products include dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The firm's products and solutions are mainly applied in the treatment of various diseases and medical conditions. The firm mainly operates in the domestic market.
Recently from Cashu
China Pharma Holdings Engages in Taiwan’s TCM Showcase at CPHI Frankfurt 2025
Taiwan Showcases Traditional Chinese Medicine at CPHI Frankfurt 2025 Taiwan's commitment to advancing Traditional Chinese Medicine (TCM) receives a significant boost as the Taiwan Pavilion concludes i…
China Pharma Holdings Highlights Taiwan's TCM Pavilion Success at CPHI Frankfurt 2025
Taiwan's Traditional Chinese Medicine Pavilion Shines at CPHI Frankfurt 2025 Taiwan's inaugural Traditional Chinese Medicine (TCM) Pavilion, organized by the Taiwan Institute for Economic Research and…
China Pharma Holdings: Taiwan's TCM Pavilion Shines at CPHI Frankfurt 2025
### Taiwan's Traditional Chinese Medicine Pavilion Makes a Splash at CPHI Frankfurt 2025 The Taiwan Traditional Chinese Medicine (TCM) Pavilion marks a significant milestone for Taiwan's health sector…
Kexing Biopharm Expands Global Reach at CPHI Frankfurt 2025 to Enhance Market Position
Kexing Biopharm Strengthens Global Footprint at CPHI Frankfurt 2025 Kexing Biopharm actively participates in CPHI Frankfurt 2025 from October 28 to 30, showcasing its extensive product portfolio and i…